501
Views
16
CrossRef citations to date
0
Altmetric
Research Articles

Virtual screening, molecular dynamics, density functional theory and quantitative structure activity relationship studies to design peroxisome proliferator-activated receptor-γ agonists as anti-diabetic drugs

, , , , &
Pages 728-742 | Received 16 Sep 2019, Accepted 05 Jan 2020, Published online: 25 Jan 2020

References

  • Adams, M. J. (2004). Chemometrics in analytical spectroscopy. doi:10.1039/9781847550484.
  • Alam, S., & Khan, F. (2017). 3D-QSAR studies on Maslinic acid analogs for anticancer activity against Breast Cancer cell line MCF-7. Scientific Reports, 7(1), 6019. doi:10.1038/s41598-017-06131-0
  • Benet, L. Z., Hosey, C. M., Ursu, O., & Oprea, T. I. (2016). BDDCS, the Rule of 5 and drugability. Advanced Drug Delivery Reviews, 101, 89–98. doi:10.1016/j.addr.2016.05.007
  • Berger, J., & Moller, D. E. (2002). The mechanisms of action of PPARs. Annual Review of Medicine, 53(1), 409–435. doi:10.1146/annurev.med.53.082901.104018
  • Berger, J. P., Akiyama, T. E., & Meinke, P. T. (2005). PPARs: Therapeutic targets for metabolic disease. Trends in Pharmacological Sciences, 26(5), 244–251. doi:10.1016/j.tips.2005.03.003
  • Berhanu, W. M., Pillai, G. G., Oliferenko, A. A., & Katritzky, A. R. (2012). Quantitative structure-activity/property relationships: The ubiquitous links between cause and effect. ChemPlusChem, 77(7), 507–517. doi:10.1002/cplu.201200038
  • Bibi, S., & Sakata, K. (2016). Current status of computer-aided drug design for Type 2 Diabetes. Current Computer Aided-Drug Design, 12(2), 167–177. doi:10.2174/1573409912666160426120709
  • Chandra, V., Huang, P., Hamuro, Y., Raghuram, S., Wang, Y., Burris, T. P., & Rastinejad, F. (2008). Structure of the intact PPAR-γ–RXR-α nuclear receptor complex on DNA. Nature, 456(7220), 350–356. doi:10.1038/nature07413
  • Choong, Y. S., Tye, G. J., & Lim, T. S. (2013). Minireview: Applied structural bioinformatics in proteomics. The Protein Journal, 32(7), 505–511. doi:10.1007/s10930-013-9514-1
  • Creswell, J. W., & Plano Clark, V. L. (2011). Designing and conducting mixed methods research. Los Angeles, CA: SAGE Publications.
  • Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7(1), 42717. doi:10.1038/srep42717
  • De Jong, S. (1990). Multivariate calibration, H. Martens and T. Naes, Wiley, New York, 1989. ISBN 0 471 90979 3. Price: £75.00, US$138.00. No. of pages: 504. Journal of Chemometrics, 4(6), 441–441. doi:10.1002/cem.1180040607
  • Demircioğlu, Z., Kaştaş, Ç. A., & Büyükgüngör, O. (2015). Theoretical analysis (NBO, NPA, Mulliken Population Method) and molecular orbital studies (hardness, chemical potential, electrophilicity and Fukui function analysis) of (E)-2-((4-hydroxy-2-methylphenylimino)methyl)-3-methoxyphenol. Journal of Molecular Structure, 1091, 183–195. doi:10.1016/j.molstruc.2015.02.076
  • Fakayode, S. O., Busch, K. W., & Busch, M. A. (2009). Chemometric approach to chiral recognition using molecular spectroscopy. In Encyclopedia of analytical chemistry. Chichester, UK: John Wiley & Sons, Ltd. doi:10.1002/9780470027318.a9082.
  • Fakayode, S. O., Mitchell, B. S., & Pollard, D. A. (2014). Determination of boiling point of petrochemicals by gas chromatography–mass spectrometry and multivariate regression analysis of structural activity relationship. Talanta, 126, 151–156. doi:10.1016/j.talanta.2014.03.037
  • Frisch, M. J., Trucks, G. W., Schlegel, H. B., Scuseria, G. E., Robb, M. A., Cheeseman, J. R., … Fox, D. J. (2009). Gaussian 09, Revision C.01. –Wallingford: Gaussian, Inc.
  • Funar-Timofei, S., Borota, A., & Crisan, L. (2017). Combined molecular docking and QSAR study of fused heterocyclic herbicide inhibitors of D1 protein in photosystem II of plants. Molecular Diversity, 21(2), 437–454. doi:10.1007/s11030-017-9735-x
  • Gale, E. A. (2001). Lessons from the glitazones: A story of drug development. The Lancet, 357(9271), 1870–1875. doi:10.1016/S0140-6736(00)04960-6
  • Grygiel-Górniak, B. (2014). Peroxisome proliferator-activated receptors and their ligands: Nutritional and clinical implications – a review. Nutrition Journal, 13(1), 10. doi:10.1186/1475-2891-13-17
  • Hamadache, M., Benkortbi, O., Hanini, S., & Amrane, A. (2018). QSAR modeling in ecotoxicological risk assessment: Application to the prediction of acute contact toxicity of pesticides on bees (Apis mellifera L.). Environmental Science and Pollution Research, 25(1), 896–907. doi:10.1007/s11356-017-0498-9
  • Jones, G., Willett, P., Glen, R. C., Leach, A. R., & Taylor, R. (1997). Development and validation of a genetic algorithm for flexible docking. Journal of Molecular Biology, 267(3), 727–748. doi:10.1006/jmbi.1996.0897
  • Kahn, B. B., & Flier, J. S. (2000). Obesity and insulin resistance. Journal of Clinical Investigation, 106(4), 473–481. doi:10.1172/JCI10842
  • Knaak, J. B., Dary, C. C., Power, F., Thompson, C. B., & Blancato, J. N. (2004). Physicochemical and biological data for the development of predictive organophosphorus pesticide QSARs and PBPK/PD models for human risk assessment. Critical Reviews in Toxicology, 34(2), 143–207. doi:10.1080/10408440490432250
  • Krieger, E., Darden, T., Nabuurs, S. B., Finkelstein, A., & Vriend, G. (2004). Making optimal use of empirical energy functions: Force-field parameterization in crystal space. Proteins: Structure, Function, and Bioinformatics, 57(4), 678–683. 10.1002/prot.20251.
  • Lavecchia, A., & Giovanni, C. (2013). Virtual screening strategies in drug discovery: A critical review. Current Medicinal Chemistry, 20(23), 2839–2860. doi:10.2174/09298673113209990001
  • Lehrke, M., & Lazar, M. A. (2005). The many faces of PPARgamma. Cell, 123(6), 993–999. doi:10.1016/j.cell.2005.11.026
  • Liu, C.-H., Chen, X.-Y., Qin, P.-W., Qi, Z.-Q., Ji, M.-S., Liu, X.-Y., … Cui, Z.-N. (2017). Synthesis, fungicidal activity, and structure activity relationship of β-Acylaminocycloalkylsulfonamides against Botrytis cinerea. Scientific Reports, 7(1), 42096. doi:10.1038/srep42096
  • Mazumder, M., Ponnan, P., Das, U., Gourinath, S., Khan, H. A., Yang, J., & Sakharkar, M. K. (2017). Investigations on binding pattern of kinase inhibitors with PPAR γ: Molecular docking, molecular dynamic simulations, and free energy calculation studies. PPAR Research, 2017, 1–11. doi:10.1155/2017/6397836
  • Mukherjee, R., Jow, L., Croston, G. E., & Paterniti, J. R. (1997). Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPAR 2 versus PPAR 1 and activation with retinoid X receptor agonists and antagonists. Journal of Biological Chemistry, 272(12), 8071–8076. doi:10.1074/jbc.272.12.8071
  • Obanda, D. N., Ribnicky, D., Yu, Y., Stephens, J., & Cefalu, W. T. (2016). An extract of Urtica dioica L. mitigates obesity induced insulin resistance in mice skeletal muscle via protein phosphatase 2A (PP2A). Scientific Reports, 6 (1), 22222. doi:10.1038/srep22222
  • Pack, S. (1991). Factor analysis in chemistry, (2nd edition), E. R. Malinowski, Wiley-Interscience, 1991. ISBN 0-471-53009-3. Price £43.70. Journal of Chemometrics, 5(6), 545–545. doi:10.1002/cem.1180050607
  • Pedersen, S. W., Hultqvist, G., Strømgaard, K., & Jemth, P. (2014). The role of backbone hydrogen bonds in the transition state for protein folding of a PDZ Domain. PLoS One, 9(4), e95619. doi:10.1371/journal.pone.0095619
  • Rowland, M., Tozer, T. N., Derendorf, H., & Hochhaus, G. (2011). Clinical pharmacokinetics and pharmacodynamics. Baltimore, MD: Lippincott Williams & Wilkins.
  • Ruark, C. D., Hack, C. E., Robinson, P. J., Anderson, P. E., & Gearhart, J. M. (2013). Quantitative structure–activity relationships for organophosphates binding to acetylcholinesterase. Archives of Toxicology, 87(2), 281–289. doi:10.1007/s00204-012-0934-z
  • Sarraf, P., Mueller, E., Smith, W. M., Wright, H. M., Kum, J. B., Aaltonen, L. A., … Eng, C. (1999). Loss-of-function mutations in PPAR gamma associated with human colon cancer. Molecular Cell, 3(6), 799–804. doi:10.1016/S1097-2765(01)80012-5
  • Schrödinger. (2015). PyMOL | www.pymol.org.
  • Schultz, T. W., & Aptula, A. O. (2016). Kinetic-based reactivity for Michael acceptors: Structural activity relationships and its relationship to excess acute fish toxicity. Bulletin of Environmental Contamination and Toxicology, 97(6), 752–756. doi:10.1007/s00128-016-1871-y
  • Speck-Planche, A., Kleandrova, V. V., & Rojas-Vargas, J. A. (2011). QSAR model toward the rational design of new agrochemical fungicides with a defined resistance risk using substructural descriptors. Molecular Diversity, 15(4), 901–909. doi:10.1007/s11030-011-9320-7
  • Srivastava, V., Sinha, D., Tiwari, A. K., Sharma, H., Bala Sharma, R., Singh, V. K., & Mishra, A. K. (2010). Quantitative structure–Activity relationship analysis of 4(3H)-Quinazolone derivatives as tyrosine kinase inhibitors by multiple linear regression. Cancer Biotherapy and Radiopharmaceuticals, 25(5), 559–562. doi:10.1089/cbr.2010.0791
  • Susnow, R. G., & Dixon, S. L. (2003). Use of robust classification techniques for the prediction of human cytochrome P450 2D6 Inhibition. Journal of Chemical Information and Computer Sciences, 43(4), 1308–1315. doi:10.1021/ci030283p
  • Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31, 455–461. doi:10.1002/jcc.21334
  • Venko, K., Župerl, Š., & Novič, M. (2014). Prediction of antiprion activity of therapeutic agents with structure–activity models. Molecular Diversity, 18(1), 133–148. doi:10.1007/s11030-013-9477-3
  • Waki, H., Park, K. W., Mitro, N., Pei, L., Damoiseaux, R., Wilpitz, D. C., … Tontonoz, P. (2007). The small molecule harmine is an antidiabetic cell-type-specific regulator of PPARγ Expression. Cell Metabolism, 5(5), 357–370. doi:10.1016/j.cmet.2007.03.010
  • Worachartcheewan, A., Prachayasittikul, V., Toropova, A. P., Toropov, A. A., & Nantasenamat, C. (2015). Large-scale structure-activity relationship study of hepatitis C virus NS5B polymerase inhibition using SMILES-based descriptors. Molecular Diversity, 19(4), 955–964. doi:10.1007/s11030-015-9614-2
  • Yan, H., Xie, H., Ying, Y., Li, J., Wang, X., Xu, X., & Zheng, X. (2018). Pioglitazone use in patients with diabetes and risk of bladder cancer: A systematic review and meta-analysis. Cancer Management and Research, 10, 1627–1638. doi:10.2147/CMAR.S164840
  • Zhang, X., Liu, H., Sun, B., Sun, Y., Zhong, W., Liu, Y., … Yang, C. (2016). Novel podophyllotoxin derivatives as partial PPARγ agonists and their effects on insulin resistance and Type 2 diabetes. Scientific Reports, 6(1), 37323. doi:10.1038/srep37323
  • Zhao, Y., & Truhlar, D. G. (2008). The M06 suite of density functionals for main group thermochemistry, thermochemical kinetics, noncovalent interactions, excited states, and transition elements: Two new functionals and systematic testing of four M06-class functionals and 12 other function. Theoretical Chemistry Accounts, 120(1–3), 215–241. doi:10.1007/s00214-007-0310-x
  • Zoete, V., Grosdidier, A., & Michielin, O. (2007). Peroxisome proliferator-activated receptor structures: Ligand specificity, molecular switch and interactions with regulators. Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, 1771(8), 915–925. Vol. doi:10.1016/j.bbalip.2007.01.007

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.